We demonstrated previously a negative association of granulosa cell cocaine-and amphetamine-regulated transcript (CARTPT) expression with follicle health status and inhibitory effects of the matureCARTPTpeptide(CART)onfollicle-stimulatinghormone(FSH) signal transduction in vitro, resulting in reduced bovine granulosa cell CYP19A1 mRNA and estradiol production. The objectives of this study were to investigate temporal regulation of granulosa cell CARTPT expression (granulosa cell mRNA and follicular fluid CART peptide concentrations) during follicular waves, CART regulation of androstenedione production (precursor for estradiol biosynthesis) by thecal tissue collected at specific stages of a follicular wave, FSH regulation of granulosa cell CARTPT mRNA expression, and the ability of CART to inhibit granulosa cell estradiol production and CYP19A1 mRNA expression when administered in vivo. CART concentrations in healthy, estrogenactive follicles (estradiol greater than progesterone in follicular fluid) decreased after dominant follicle selection, and CARTPT mRNA was lower in healthy, estrogen-active versus estrogeninactive atretic follicles (progesterone greater than estradiol) collected at the predeviation and early dominance stages. CART treatment reduced luteinizing hormone-induced androstenedione production by thecal tissue collected at predeviation and early dominance stages but not at later stages of a follicular wave. The FSH or insulin-like growth factor 1 treatment in vitro reduced granulosa cell CARTPT mRNA in a dose-dependent fashion. Administration of CART in vivo into follicles at the early dominance stage reduced follicular fluid estradiol concentrations and granulosa cell CYP19A1 mRNA. Collectively, results support a potential stage-specific regulatory role for CART in negative regulation of estradiol production associated with selection of the dominant follicle.
INTRODUCTION
Antral follicle development occurs in a characteristic wavelike pattern in monotocous species, including cattle and humans [1] [2] [3] . A transient increase in serum follicle-stimulating hormone (FSH) precedes the onset of a follicular wave and stimulates emergence of a cohort of small antral follicles. Typically, in the face of declining FSH concentrations, a single dominant follicle out of this cohort is selected to continue to grow to ovulatory size [4] , and it produces increased amounts of estradiol. The remaining, smaller ''subordinate'' follicles rapidly lose their capacity to produce estradiol and die via atresia [2, [5] [6] [7] . Production of estradiol by the dominant follicle is essential for follicular growth and triggers the preovulatory gonadotropin surge to promote resumption of meiosis and ovulation [3, 8, 9] . Estradiol-producing capacity is lost in ovarian follicles before apoptosis and morphological signs of atresia [6, 10] . Although the key role of pituitary gonadotropins, such as FSH, in regulation of ovarian folliculogenesis is well established, the potential role of local intrafollicular regulatory molecules in negative regulation of FSH action and acquisition of follicle dominance is not completely understood.
A growing body of evidence supports a novel local role for cocaine-and amphetamine-regulated transcript (CARTPT) in negative regulation of antral follicle development in cattle [11] [12] [13] . CARTPT expression was first discovered in the brain, where it is best known for its anorexigenic [14] [15] [16] [17] , neuroendocrine [18] [19] [20] [21] [22] , and antipsychostimulant actions [23] [24] [25] . Ovarian expression of CARTPT mRNA was first discovered during sequencing of expressed sequence tags from a bovine oocyte cDNA library [26] , and ovarian CARTPT expression is most robust in granulosa cells [13] .
Recent results support a potential novel local role for granulosa cell CARTPT gene expression in negative regulation of FSH signal transduction and estradiol production by bovine granulosa cells [11] . Treatment of cultured granulosa cells with the mature form of the CARTPT peptide (CART) blocks FSHstimulated granulosa cell estradiol production through inhibition of FSH-induced cAMP accumulation, Ca 2þ influx, and CYP19A1 mRNA expression via a G o/i subclass of G proteindependent pathway [11] . CART also accelerates termination of FSH-induced mitogen-activated protein kinase 1 (MAPK1) and AKT1 signaling in bovine granulosa cells via upregulation of expression and reduced degradation of specific MAPK phosphatases [12] . Furthermore, granulosa cell CARTPT expression is negatively associated with follicle health status and estradiol-producing capacity as granulosa cell CARTPT mRNA, and follicular fluid concentrations of CART peptide are higher in estrogen-inactive atretic versus estrogen-active healthy follicles collected from abattoir ovaries at random stages of the first follicular wave [13] . Estrogen-active follicles (ratio of estradiol to progesterone greater than 1) have biochemical characteristics of healthy growing follicles, whereas estrogen-inactive follicles (ratio of estradiol to progesterone less than 1) are destined to undergo atresia [6, 27, 28] .
The results above support a potential intrafollicular regulatory role for CARTPT in negative regulation of estradiol production during bovine follicular development. However, those results were obtained using samples collected from ovaries of abattoir origin at undefined stages of a follicular wave. The regulation of CARTPT expression during a follicular wave, intrafollicular sites of CARTPT action, and the ability of CARTPT to regulate estradiol production in vivo have not been investigated in detail. Such information is critical to elucidation of the precise physiological role of CARTPT in regulation of follicular development. Hence, the objectives of the present studies were to determine the temporal regulation of granulosa cell CARTPT expression in follicles collected at specific stages of a follicular wave, the ability of CART to regulate androstenedione production (a precursor for estradiol biosynthesis) by thecal tissue collected at specific stages of a follicular wave, the effects of FSH and insulin-like growth factor 1 (IGF1) treatment on granulosa cell CARTPT expression, and the ability of CART to inhibit granulosa cell estradiol production and CYP19A1 mRNA expression when administered in vivo.
MATERIALS AND METHODS

Materials
All materials were obtained from Sigma-Aldrich (St. Louis, MO) unless stated otherwise.
Animal Model and Sample Collection
All animal procedures were approved by the All University Committee on Animal Use and Care at Michigan State University. Estrus was synchronized in 45 cross-bred beef heifers with two injections of prostaglandin F 2a (PGF 2a ; Prostamate; IVX Animal Health, St. Joseph, MO) administered 11 days apart, and follicular growth was observed and recorded by daily ultrasonography. Ovaries were removed from heifers at the following stages of the first follicular wave (depicted in Fig. 1 ): predeviation (approximately Day 3 after estrus; Day 1.5 after emergence [first day a follicle .4 mm is detected by ovarian ultrasonography] of the first follicular wave; n ¼ 12), early dominance (Days 4-5 after estrus; first day in wave when one follicle in the cohort is 2 mm larger than others; n ¼ 9), mid dominance (Days 6-9 after estrus; second day in wave that dominant follicle does not increase in size; n ¼ 8), loss of dominance (Days 10-12 after estrus; first day that a new cohort in second follicular wave appears; n ¼ 8), and an ovulatory wave (preovulatory; 1 day after PGF 2a injection on Day 7 after estrus; n ¼ 8). The three largest (F1, F2, and F3) follicles were isolated from the predeviation group, the two largest from the early dominance group, and only the largest follicle (F1) was isolated from the mid dominance, loss of dominance, and preovulatory groups. Granulosa cells and follicular fluid were harvested using previously described procedures [13] for determination of granulosa cell CARTPT mRNA abundance and follicular fluid concentrations of estradiol, progesterone, and CART. Thecal tissue was removed from the same follicles for in vitro culture experiments described below.
For studies aimed at investigating the ability of CART to regulate follicular estradiol production and granulosa cell CYP19A1 mRNA in vivo, estrus was synchronized in 11 nonlactating Holstein cows, and follicular growth was observed and recorded by daily ultrasonography. Animals were randomly assigned to treatments upon detection of estrus. Administration of CART (rat CART 55-102 [American Peptide Co., Sunnyvale, CA]; identical in sequence to bovine CART [13] ) into follicles at the early dominance stage was performed using ultrasound-mediated intrafollicular injection procedures performed as we reported previously [29] [30] [31] . Holstein cows, rather than beef heifers, were used as the model in these experiments because the size and flaccidity of the reproductive tract facilitates manipulations necessary for successful ultrasoundmediated intrafollicular injection. A single follicle per animal (at the early dominance stage) was injected with 100 ll of CART (n ¼ 6) or vehicle (sterile saline; n ¼ 5). Amounts of CART infused were based on follicle volume calculations [29] and designed to achieve initial intrafollicular concentrations of CART (10 lM) 100-fold greater than the effective concentrations of CART we have shown previously to inhibit granulosa cell estradiol production and CYP19A1 mRNA in vitro [11] . Follicle sizes at the time of the intrafollicular injections were 11.2 6 0.7 mm and 11.7 6 0.7 mm for vehicle and CARTtreated cows, respectively. Follicle rupture or leakage was monitored by ultrasonography after injection, and criteria for successful intrafollicular injection were as reported previously [29] . Follicular fluid and granulosa cells were aspirated from CART-treated and diluent-treated follicles 24 h after intrafollicular injection for assay of follicular fluid estradiol, progesterone, androstenedione, and CART concentrations and granulosa cell CYP19A1 mRNA abundance, as described below.
Culture of Thecal Tissue
Thecal tissue culture was conducted as described by Jo and Fortune [32] , with minor modifications. Thecal tissue from individual follicles was minced into pieces of approximately equivalent size and cultured (two pieces per well) in 500 ll of Eagle minimum essential medium supplemented with L-glutamine (2 mM), penicillin and streptomycin (50 U/ml and 50 lg/ml, respectively), nonessential amino acids (0.1 mM), insulin (27.6 mIU/ml), and transferrin (5 lg/ml) in a humidified environment of 5% CO 2 and air at 378C for 24 h. Treatments were administered in duplicate-quadruplicate and consisted of media alone, bovine luteinizing hormone (LH; 4 ng/ml; AFP-11743B; obtained from Dr. A. F. Parlow, National Hormone Peptide Program, Torrance, CA), CART (0.1 lM; American Peptide), or CART (0.1 lM) plus LH (4 ng/ml). Thecal tissue and media were harvested after termination of culture and stored at À808C for subsequent protein and androstenedione assays. Doses of CART and LH used were based on results of previous studies [11, 32] .
Granulosa Cell Culture
Serum-free, long-term granulosa cell culture was performed using our previously described procedures [11, 12] . Treatments consisted of media alone;
Graphical depiction of experimental model used for collection of ovarian follicles at specific stages of a follicular wave. Follicles were collected at predeviation (PD; approximately Day 3 after estrus; Day 1.5 after follicle wave emergence), early dominance (ED; Days [d] 4-5 after estrus; first day in wave when one follicle in the cohort is 2 mm larger than others), mid dominance (MD; Days 6-9 after estrus; second day in wave that the dominant follicle does not increase in size), loss of dominance (LD; Days 10-12 after estrus; first day that a new cohort in second follicular wave appears), and preovulatory (PO; 1 day after PGF 2a [PG] injection on Day 7 after estrus) stages of development. The three largest (F1, F2, and F3) follicles were isolated from the PD group, the two largest (F1 and F2) were isolated from the ED group, and only the largest follicle (F1) was isolated from MD, LD, and PO groups. media containing 0.01, 0.1, or 0.5 ng/ml ovine FSH (NIDDK-oFSH-20; AFP-7028D; National Hormone Peptide Program); or media containing 0, 1, 10, or 100 ng/ml LR3 IGF1 (Sigma, St. Louis, MO). Treatments were administered upon initiation of culture and continued for 7 days. Every 48 h, 75% of media was replaced with fresh medium containing appropriate treatments. On Day 7, media were removed, and the cells were washed two times with Dulbecco PBS, trypsinized, and cell number determined as we reported previously [11] . After collection, cells were stored at À808C for total RNA isolation and determination of the effects of FSH and IGF1 treatments on granulosa cell CARTPT mRNA abundance.
Radioimmunoassays for Estradiol, Progesterone, Androstenedione, and CART Radioimmunoassays for estradiol, progesterone, androstenedione (Siemens Medical Diagnostics, Los Angeles, CA), and CART (Phoenix Pharmaceuticals, Burlingame, CA) in follicular fluid were conducted according to previously published procedures [13, 33] . Intraassay coefficients of variation for assays of estradiol, progesterone, androstenedione, and CART in follicular fluid were 6.7%, 7.2%, 5.8%, and 8.9%, respectively. Health status of each follicle was determined by calculating the ratio between estradiol and progesterone concentrations in follicular fluid, with follicles with an estradiol:progesterone ratio !1 considered estrogen active and healthy, whereas follicles with an estradiol:progesterone ratio ,1 were considered estrogen inactive and atretic [6, 27, 28] .
Concentrations of androstenedione in culture medium were measured by radioimmunoassay (Siemens Medical Diagnostics) and normalized relative to thecal tissue protein content per well [34] . The intraassay and interassay coefficients of variation for assays of androstenedione in thecal tissue culture medium were 8.7% and 12.7%, respectively.
Real-Time PCR Analysis of Granulosa Cell CARTPT and CYP19A1 mRNAs RNA isolation, cDNA synthesis, and real-time PCR analysis of granulosa cell mRNA abundance for CARTPT (in cultured granulosa cells stimulated with FSH or IGF1) and CYP19A1 (in granulosa cells harvested from follicles injected with CART in vivo) were conducted using previously described procedures [11, 13] . Abundance of mRNA for CARTPT and CYP19A1 was normalized relative to abundance of ACTB mRNA.
Statistical Analysis
Follicle size, concentrations of steroids and CART in follicular fluid, and CARTPT mRNA in granulosa cells collected from beef heifers were statistically analyzed using the Proc Mixed function of the Statistical Analysis Software Version 8.0 [35] . Data were examined for normality of distribution with the Shapiro-Wilk test, and when heterogeneity of variance was detected, data were natural log-transformed before analyses. Main effects included stage of follicular development, follicle size or class (estrogen active or estrogen inactive), and their interaction. Concentrations of androstenedione in media samples were also analyzed using Proc Mixed. The main effects tested were stage of follicle growth, treatments (control, LH, CART, or LH plus CART), and their interactions. Effects of intrafollicular CART injection on concentrations of steroids and CART in follicular fluid and CYP19A1 mRNA in granulosa cells were analyzed by ANOVA. When main effects were significant (P 0.05), Bonferroni test was used to determine whether differences existed between individual means. All data are presented as mean 6 SEM.
RESULTS
Temporal Regulation of Granulosa Cell CARTPT mRNA and Follicular Fluid Concentrations of CART Peptide During Follicular Waves
Mean diameters for F1-F3 follicles harvested at the predeviation stage of development, the two largest follicles (F1-F2) at the early dominance stage, and the largest follicle (F1) at the mid dominance, loss of dominance, and preovulatory stages are depicted in Figure 2A and confirm anticipated size characteristics of follicles collected at described stages of development. Corresponding mean concentrations of granulosa cell CARTPT mRNA and follicular fluid concentrations of the CART peptide for healthy (estrogen-active) follicles versus atretic (estrogen-inactive) follicles collected at the above stages of development are depicted in Figure 2 , B and C. Granulosa cell CARTPT mRNA concentrations were higher in estrogeninactive atretic follicles versus estrogen-active healthy follicles collected at the predeviation and early dominance stages (P ,
FIG. 2. Follicle diameters and temporal changes in granulosa cell
CARTPT mRNA and follicular fluid CART peptide concentrations in bovine follicles collected at specific stages of a follicular wave. A) Diameters (as determined by ultrasonography) of follicles collected at predeviation (PD), early dominance (ED), mid dominance (MD), loss of dominance (LD), and preovulatory (PO) stages of development. The three largest (F1, F2, and F3) follicles were isolated from the PD group, the two largest (F1 and F2) were isolated from the ED group, and only the largest follicle (F1) was isolated from the MD, LD, and PO groups. B) Relative abundance of CARTPT mRNA in the granulosa cells of estrogen-active (EA) and estrogen-inactive (EI) follicles collected at PD, ED, MD, LD, and PO stages of development. C) Follicular fluid concentrations of the CART peptide in EA and EI follicles collected at PD, ED, MD, LD, and PO stages of development. Data depicted represent mean 6 SEM of data derived from 12, 9, 8, 8, and 8 animals per time point, respectively. In each panel, bars without common superscript letters differ (P , 0.05). 582 0.05), and they were relatively low in follicles collected at remaining stages of development (Fig. 2B) . Follicular fluid concentrations of the CART peptide (Fig. 2C) were higher in estrogen-active follicles collected prior to dominant follicle selection (predeviation stage) and were reduced in estrogenactive follicles collected at subsequent stages of development (P , 0.05). Follicular fluid CART concentrations were negatively associated with follicle health status and were higher in estrogen-inactive atretic follicles versus estrogenactive healthy follicles collected at the predeviation and early dominance stages (P , 0.05). A slight increase in follicular fluid CART concentrations ( Fig. 2C ; P , 0.05), but not CARTPT mRNA (Fig. 2B) , associated with atresia of the dominant follicle was observed.
Effects of CART Treatment on Thecal Androstenedione Production In Vitro
Effects of CART treatment on basal and LH-stimulated androstenedione production by thecal tissue collected at the predeviation and early dominance stages are depicted in Figure  3 . A significant effect of follicle health status on concentrations of androstenedione produced by thecal tissue collected at the predeviation and early dominance stages was not observed, so results for thecal tissue harvested from estrogen-active and estrogen-inactive follicles were pooled. Regardless of stage of the follicular wave, no effects of CART treatment on basal androstenedione production were observed. However, the stimulatory effects of LH on androstenedione production by thecal tissue collected at the predeviation stage were blocked by CART treatment (P , 0.05). Furthermore, CART treatment resulted in a 48% decrease in LH-induced androstenedione production by thecal tissue collected at the early dominance stage (P , 0.05). Effects of CART treatment on LH-stimulated androstenedione production by thecal tissue collected at the mid dominance, loss of dominance, and preovulatory stages were not observed (Supplemental Fig. S1 , available online at www.bioloreprod.org).
Effect of FSH or IGF1 Treatment on Granulosa Cell CARTPT mRNA Expression In Vitro
Effects of FSH and IGF1 treatment on granulosa cell CARTPT mRNA abundance are depicted in Figure 4 , A and B, respectively. Granulosa cell abundance of CARTPT mRNA was reduced in response to increasing concentrations of FSH in a dose-dependent fashion ( Fig. 4A ; P , 0.05). Granulosa cell CARTPT mRNA abundance was also reduced in response to treatment with 10 and 100 ng/ml IGF1, but not 1 ng/ml IGF1 ( Fig. 4B; P , 0.05) .
Effects of Intrafollicular CART Treatment In Vivo on Follicular Fluid Estradiol Concentrations and Granulosa Cell CYP19A1 mRNA Abundance
The effects of intrafollicular CART injection (into bovine follicles at the early dominance stage) on follicular fluid concentrations of estradiol and granulosa cell CYP19A1 mRNA abundance 24 h after treatment administration are depicted in Figure 5 , A and B. At 24 h after intrafollicular injection, follicular fluid concentrations of CART peptide were elevated approximately 3-fold in follicles subjected to intrafollicular CART injection (105 6 15.6 ng/ml) relative to vehicle-injected follicles (33 6 2.6 ng/ml), and concentrations of CART in injected follicles mimicked those present in estrogen-inactive subordinate follicles harvested at the early dominance stage. No effects of intrafollicular CART treatment on follicle size (10.6 6 0.8 mm for diluent-injected versus 11.6 6 0.8 mm for CART-injected follicles) or follicular fluid concentrations of androstenedione (24.8 6 6.7 ng/ml versus 17.0 6 1.0 ng/ml for CART-injected follicles) were detected. However, intrafollicular CART injection resulted in a greater than 50% reduction in follicular fluid estradiol concentrations ( Fig. 5A ; P , 0.01) and an approximately 96% decrease in granulosa cell CYP19A1 mRNA abundance ( Fig. 5B ; P , 0.02).
DISCUSSION
Sustained production of estradiol by ovulatory follicles is critical to fertility in humans and other mammalian species, but more than 99% of ovarian follicles lose estradiol-producing capacity and die at earlier stages of folliculogenesis. It is well established that each follicular wave is preceded by a transient elevation in circulating FSH concentrations [36] . A cohort of follicles begins to grow at the initiation of each follicular wave. One of the follicles within the cohort continues to grow and becomes the dominant follicle, whereas the rest of the follicles within the cohort become subordinate follicles and undergo atresia. A key characteristic of the dominant follicle is its greater capacity to produce estradiol in the face of low FSH concentrations. Although evidence indicates that the future dominant follicle has greater responsiveness to FSH at the onset of selection than does the future subordinate follicle [1] , FSHR mRNA [37] [38] [39] and FSHR receptor binding [27, 28, 40, 41] do not increase coincidentally with dominant follicle selection in cattle. Hence, it is plausible that local (intrafollicular) inhibition of FSH action could be functionally linked to the process of dominant follicle selection. This study for the first time demonstrates that intrafollicular administration of CART in vivo into early dominant follicles results in a dramatic reduction in follicular fluid estradiol concentrations and granulosa cell CYP19A1 mRNA levels. Furthermore, the present studies clearly demonstrate pronounced temporal regulation of granulosa cell CARTPT expression near the time of dominant follicle selection, as well as negative regulation of CARTPT REGULATION OF DOMINANT FOLLICLE SELECTION granulosa cell CARTPT mRNA in vitro in response to FSH or IGF1 treatment. Previous studies established a negative relationship between CARTPT expression and follicle health status using follicle samples of abattoir origin at random stages of a follicular wave [13] , and they demonstrated potent inhibitory effects of CART treatment on multiple components of the FSH signal transduction pathway, resulting in reduced granulosa cell estradiol production in vitro [11, 12] . Collectively, results to date establish CART as a potential important local negative regulator of FSH action and estradiol production associated with dominant follicle selection.
The temporal and hormonal regulation of CARTPT expression observed in the present studies is consistent with a potential role for the CART peptide in selection, but not atresia, of the dominant follicle in cattle. We have proposed previously that CARTPT may function as a gatekeeper of the ovulatory quota in mono-ovulatory species [12] . Granulosa cell CARTPT expression (mRNA and follicular fluid CART peptide concentrations) was higher in estrogen-inactive atretic follicles versus estrogen-active healthy follicles collected at the predeviation and early dominance stages of a follicular wave, and follicular fluid CART concentrations in healthy follicles were decreased coincidentally with dominant follicle selection.
Maximal estradiol-secreting capacity of follicles that undergo selection during the luteal phase is short lived. Available evidence indicates that growth of dominant follicles involves a shift from FSH dependence to LH dependence in cattle [42, 43] , but effects of CART on LH-induced granulosa cell steroidogenesis have not been investigated. Dominant follicles ultimately undergo a decline in estradiol production, accompanied by decreased gonadotropin receptor and steroidogenic enzyme mRNA abundance [37, 44] . Enhanced LH pulsatility associated with luteolysis during the follicular phase, however, rescues the dominant ovulatory follicle and facilitates a further increase in estradiol production, culminating in initiation of the preovulatory LH surge. However, only subtle changes in follicular fluid CART concentrations associated with loss of dominance or progression of dominant follicles to the preovulatory stage were observed in the present studies. Hence, a role for CARTPT in promoting atresia of dominant nonovulatory follicles seems less likely, but further studies will be required to confirm whether granulosa cell responsiveness to CART is also temporally regulated during follicular waves in cattle and to further rule out a role for CART in the negative regulation of estradiol production associated with atresia of dominant follicles in cattle.
Results of the current studies demonstrate pronounced, dose-dependent inhibitory effects of FSH treatment on granulosa cell CARTPT mRNA expression in vitro. The FSH treatment of granulosa cells results in increased cAMP levels, activation of protein kinase A [11] , and activation of the transcription factor CREB [45] . However, expression of CARTPT mRNA is increased in GH3 (pituitary tumor cells) in vitro [46] and in the rat nucleus accumbens in vivo [47] in response to pharmacological activation of adenylate cyclase and stimulation of the protein kinase A pathway. Furthermore, activity of the mouse Cartpt promoter in GH3 pituitary tumor cells [46] and in CATH.a (locus coeruleus-derived) cells [48] is also increased in response to cAMP stimulation. In addition, cAMP responsiveness is lost via deletion or mutation of the canonical cAMP response element in the proximal promoter region. Hence, results indicate that regulation of granulosa cell CARTPT expression is distinct from that reported previously for pituitary/neuronal cells.
The hormonal mechanisms that explain the observed divergence in CARTPT expression in future dominant versus subordinate follicles near the time of dominant follicle selection are not completely understood. A transient increase in serum FSH precedes the onset of a follicular wave and stimulates the emergence of a group of small antral follicles. Typically, in the face of declining FSH concentrations, a single dominant follicle is selected to continue to grow to ovulatory size out of this cohort [4] . However, CARTPT expression was highest early in a follicular wave, prior to when FSH levels reach their nadir, but declined thereafter. Perhaps the peak FSH concentration at the onset of a follicular wave has a role in the subsequent suppression of CART production by granulosa cells. Furthermore, it is possible that differences in FSH responsiveness between the future dominant and subordinate follicles [1] may help explain the selective reduction in CART in estrogen-active follicles accompanying dominant follicle selection. In addition, observed temporal regulation of CARTPT expression in healthy follicles associated with dominant follicle selection may also be attributed to actions of IGF1. We observed pronounced negative regulation of granulosa cell CARTPT mRNA in response to IGF1 treatment in vitro, and greater IGF1 bioavailability in the future dominant follicle has also been observed coincidentally with dominant follicle selection [4, 49, 50] .
Results of the present studies indicate that thecal cells are also responsive to CART treatment in vitro, and that CART is inhibitory to LH-induced production of androstenedione by thecal tissue collected near the time of dominant follicle selection. Elucidation of the intracellular mechanisms involved in CART inhibition of LH-induced androstenedione production will require further investigation, but effects of CART are presumably due to negative regulation of MAPK1 and AKT1 signaling. Previous studies have demonstrated that LH-induced androstenedione production by bovine thecal cells is MAPK1 [51, 52] and AKT1 [51] dependent, and CART is a potent inhibitor of FSH-induced MAPK1 and AKT1 signaling in bovine granulosa cells [12] . In contrast to results obtained in vitro, follicular fluid androstenedione concentrations were not reduced in response to intrafollicular CART administration into early dominant follicles in vivo, and dominant follicle selection in cattle is not accompanied by dramatic divergence in follicular fluid androstenedione concentrations between dominant and subordinate follicles [50] . Thus, evidence does not support a direct prominent contribution of CART regulation of thecal cell androstenedione production in vivo which could explain observed negative regulation of follicular estradiol production.
Collectively, results of our current and previous [11] [12] [13] studies support a potential functional role for CARTPT in negative regulation of FSH signaling and intrafollicular estradiol production and support a potential functional role for CARTPT in selection of dominant follicles during follicular waves in mono-ovulatory species, such as the cow and, perhaps, the human. In contrast, Cartpt is not expressed in the ovaries of rats [53] , and Cartpt mutant mice are fertile [54] . These observations suggest that polyovulatory species, such as rodents, may require a less stringent selection mechanism to ovulate multiple follicles, thus providing an evolutionary explanation for the absence of CARTPT expression in the ovary of polytocous species, and support our hypothesis that CARTPT functions as a ''gatekeeper'' of the ovulatory quota in monotocous species.
